US Bancorp

SEC CIK: 0000036104
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

ELVN holding history

Enliven Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELVN overview All 13F holders of ELVN Full Q2 2026 holdings

Shares (Q2 2026): 737
Value: $37.4K
% of portfolio: <0.1%
Quarters held: 4; Since Q2 2025

Holdings of ELVN by US Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	737	$37.4K	<0.1%	+570+341.3%	Added	Holders
Q1 2026	167	$6.55K	<0.1%	+167	New	Holders
Q4 2025	0	$0	0.0%	−111−100.0%	Sold out	Holders
Q3 2025	111	$2.27K	<0.1%	00.0%	Unchanged	Holders
Q2 2025	111	$2.23K	<0.1%	+111	New	Holders